Loss of Asxl2 leads to myeloid malignancies in mice
ASXL2 mutations are mostly found in a subset of leukemia patients with certain genetic aberrations; however the role of this protein in normal hematopoiesis and related malignancies is still unclear. Here the authors use a knock-out mouse model to uncover the role of Asxl2in hematopoiesis and leukem...
Guardado en:
Autores principales: | Jianping Li, Fuhong He, Peng Zhang, Shi Chen, Hui Shi, Yanling Sun, Ying Guo, Hui Yang, Na Man, Sarah Greenblatt, Zhaomin Li, Zhengyu Guo, Yuan Zhou, Lan Wang, Lluis Morey, Sion Williams, Xi Chen, Qun-Tian Wang, Stephen D. Nimer, Peng Yu, Qian-Fei Wang, Mingjiang Xu, Feng-Chun Yang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d8d0621e6a8f4b58bd9d7e748569e036 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis
por: Shuhei Asada, et al.
Publicado: (2018) -
Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1
por: Salima Daou, et al.
Publicado: (2018) -
HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia
por: Ganqian Zhu, et al.
Publicado: (2021) -
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
por: Jean-Baptiste Micol, et al.
Publicado: (2017) -
BAP1/ASXL1 recruitment and activation for H2A deubiquitination
por: Danny D. Sahtoe, et al.
Publicado: (2016)